- Tech Stock Insider
- Posts
- The AI Chip Stock Down A Third Right Before Its Biggest Night
The AI Chip Stock Down A Third Right Before Its Biggest Night
The hype has crashed. Tonight's numbers could change everything before the bell rings.
One of the loudest post-IPO stories of the year is trading at a fraction of its high, hours before its first real earnings test. If you have been waiting for the froth to burn off a high-beta AI hardware name, this is the window worth watching.

Standout Picks Now (Sponsored)
Every market cycle produces a handful of companies that dramatically outperform the rest.
Our latest screening has identified the 5 Stocks Set to Double — companies showing rare early-stage momentum traits.
These picks carry the same indicators that historically precede strong rallies.
Past reports highlighted stocks that surged +175%, +498%, and +673%.
Get the Free 5 Stocks Set to Double Report.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.


What Just Happened
The stock is Cerebras Systems (NASDAQ: CBRS), the wafer-scale AI chip company that IPO'd earlier this year and immediately ran up to $350. You're now looking at around $234, down about 33% from the prior close, with the 52-week range spanning $160.81 to $386.34.
Q2 earnings hit tonight, August 12, after the close. The Street is looking for around $194 million in revenue, up roughly 88% year over year. On the chart, your breakout level is $244.03.
The stock is coiling into the single biggest catalyst of its short public life, at a price well below where post-IPO buyers stepped in, so decide before the close whether you want exposure through the print.

What the Business Actually Does
Cerebras builds the largest computer chips ever made. Their Wafer-Scale Engine takes an entire silicon wafer and turns it into a single processor, the opposite of how Nvidia stitches thousands of smaller GPUs together with networking.
That design is aimed squarely at AI inference, the part of the workload that runs every ChatGPT query you send, every Claude answer, every enterprise agent.
Why should you care? Inference is where the money is now. Training the model happens once. Serving it happens billions of times. Cerebras has landed deals with OpenAI, AWS, and G42 to run inference at speeds Nvidia struggles to match on transformer models. If inference eats AI budgets over the next two years, Cerebras is one of the few names built for it.

Free hotlist (Sponsored)
"Frontier AI" could be the point of no return—when AI surpasses human intelligence.
Elon Musk warns that tipping point could arrive by the end of 2026, and according to my research, it may have already happened.
As this technology reaches a select group of companies, some stocks could surge while others struggle.
That's why I'm giving away my Frontier AI Hotlist, including six free trade ideas, to help you prepare for what's next.
Get My Frontier AI Hotlist

Which cloud platform do you think gains the most market share over the next 3 years? |

Why the Market Cares Again
The Inference Shift Is Real
The AI story used to be about who trains the biggest model. Now it is about who can serve answers cheapest and fastest. Cerebras is purpose-built for that shift, and every hyperscaler earnings call keeps hammering the same point you need to hear: inference demand is outrunning supply. That is exactly the tailwind Cerebras needs.
The Hyperscaler Validation
When AWS signs an inference deal with a startup chipmaker, that is not a marketing win. That is Amazon telling you their own Trainium roadmap has gaps. Same with the OpenAI relationship. These are the customers Nvidia would love to lock down forever, and they are actively diversifying. That matters more than any one quarter of revenue.
A Reset Into the Print
Getting a fresh IPO with a 33% pullback right into an earnings catalyst is rare. Most of the froth is gone. Expectations have reset. If tonight's print lands anywhere near the $194 million bar, you get a violent snapback. If it misses, you already have the discount priced in.

Financial Planning (Sponsored)
Switching advisors may feel like a hassle, which is why many put it off.
But the right advisor can help you make smarter decisions about retirement, taxes, and long-term wealth planning.
With SmartAsset’s no-cost tool, you can compare vetted fiduciary advisors in your area and see if it’s time for a change.
Take the Matching Quiz Now
*This example demonstrates the potential final lifetime portfolio value, accounting for estimated investment returns, tax savings and inflation over different life stages for an individual starting with $500,000 at age 45, through age 77. Under a set of core assumptions, this consumer profile is projected to have a final lifetime portfolio value of approximately $3.24 million if retaining the services of a financial advisor – not accounting for additional savings or portfolio withdrawals – versus a final estimated lifetime portfolio value of $1.56 million without the services of a financial advisor. This example is based on the valuation framework presented in SmartAsset's whitepaper "The Value of a Financial Advisor: What's It Really Worth?" (Nov. 2024). The value of professional financial advice is only an illustrative estimate and varies with each unique client's individual circumstances and portfolio composition. Carefully consider your investment objectives, risk factors, and perform your own due diligence before choosing a financial advisor.

What the Financials Are Signaling
The Growth Number
Roughly 88% year-over-year revenue growth is the whole story. In semis, that pace is elite. Most AI chip peers are growing well below that. If the print confirms the trajectory, you'll find the multiple compression argument much harder to make.
The Market Cap vs. The Opportunity
At around $53 billion, you are paying up for a business that is still small in absolute revenue. That is the risk and the setup. Every 10 points of growth surprise reprices the whole stock, in both directions.
The Cash Question
As a fresh IPO, Cerebras is sitting on a large war chest from the offering. That funds the next two to three years of scale-up without needing to tap markets. Watch the operating margin commentary tonight. That is what tells you whether growth is being bought or earned.

The Valuation Problem You Should Not Ignore
The Revenue Multiple Is Still Rich
Even after the drop, a $53 billion market cap on $194 million quarterly revenue is a big number. You are paying for a growth curve, not a business. If growth decelerates even slightly, the multiple has a long way to fall.
Customer Concentration Is the Real Risk
G42, the UAE-backed AI firm, has historically been a huge chunk of revenue. Any book where one customer dominates is fragile. Tonight's print will tell you whether the AWS and OpenAI wins are actually diversifying the base yet.
Post-IPO Lockup Risk
Cerebras IPO'd earlier this year. The 180-day lockup expires around November. That is a wall of insider supply hitting the market in about three months. Even a great Q2 does not eliminate that overhang, and you need to plan for it.

What Needs to Happen Next
Tonight's Q2 Print
Revenue north of $194 million and positive guidance for Q3 is the base case for a bounce. Anything meaningfully above $200 million with expanding gross margins triggers a rerate.
Customer Diversification Proof
Watch for management commentary on non-G42 revenue mix. If they show G42 dropping below 60% of revenue, the concentration bear thesis takes a hit.
A Clean Break Above $244
The $244.03 technical level is where sellers gave up on the way down. Watch for a reclaim after earnings to signal your reset is over.

The Risks You Should Take Seriously
Nvidia Is Not Standing Still
Blackwell and the next Rubin generation both target inference workloads Cerebras claims to own. If Nvidia closes the performance gap, the whole thesis compresses.
Lockup Expiry Supply
November brings a massive block of insider stock into circulation. Even good fundamentals can get overwhelmed by mechanical selling.
Single-Customer Downside
If G42 pauses or shifts to another supplier, revenue could air-pocket for a quarter or two before AWS and OpenAI ramps fill the gap.
Post-IPO Volatility
Names this fresh trade on flow, not fundamentals. Expect 15% swings in either direction on any headline.

How I'd Frame a Position
Do Not Chase Into the Print
Buying the afternoon of earnings is a coin flip, not an investment. The right move is to wait for the print and react to the numbers.
Scale In on Weakness
If the report misses and the stock drops another 15% to 20%, that is your entry zone. Somewhere between $185 and $210 gives you real margin of safety.
Own the Setup, Not the Trade
The medium-term story is inference share. That plays out over 12 to 18 months. Position accordingly and ignore the day-to-day noise.
If You Already Own It
Trim into any post-earnings pop above $280. Take some risk off ahead of the November lockup. You can always re-add after supply clears.

Bottom Line
Cerebras is the highest-beta AI hardware bet you can make in the public market right now. The 33% haircut heading into tonight's earnings resets expectations and gives you a cleaner risk-reward than anything the post-IPO buyers had.
Do not chase the print. Wait for the reaction, use $185 to $210 as your accumulation zone, and remember November's lockup. The setup is there. The discipline is on you.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any tech stocks you want me to check out.
Best Regards,
—Noah Zelvis
Tech Stock Insider


